Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for propofol requirement during painless hysteroscopy
ChiCTR2500113363Phase 4Not yet recruiting
- Sponsor
- Zhejiang Provincial Hospital of Traditional Chinese Medicine
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine (5 arms), sponsored by Zhejiang Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Sedation success or failure. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
oliceridine
Beyond the preview
Go deeper on ChiCTR2500113363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113363.